Equity Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Equity Compensation  
Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

 

 

    

Weighted

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

 

Shares Subject

 

Average

 

Weighted

 

Remaining

 

 

 

to Options

 

Grant Date

 

Average

 

Contractual

 

 

    

Outstanding

    

Fair Value

    

Exercise Price

    

Life (Years)

  

Balance at December 31, 2014

 

4,851,221

 

 

 

 

$

10.57

 

 

 

Granted

 

238,516

 

$

5.31

 

 

10.52

 

 

 

Exercised

 

(285,387)

 

 

 

 

 

4.87

 

 

 

Expired

 

(47,866)

 

 

 

 

 

13.92

 

 

 

Forfeited

 

(183,812)

 

 

 

 

 

14.76

 

 

 

Balance at December 31, 2015

 

4,572,672

 

 

 

 

 

10.72

 

 

 

Granted

 

50,000

 

 

4.63

 

 

8.16

 

 

 

Exercised

 

(685,798)

 

 

 

 

 

5.01

 

 

 

Expired

 

(76,907)

 

 

 

 

 

14.96

 

 

 

Forfeited

 

(83,562)

 

 

 

 

 

14.81

 

 

 

Balance at December 31, 2016

 

3,776,405

 

 

 

 

 

11.55

 

 

 

Exercised

 

(1,617,659)

 

 

 

 

 

10.48

 

 

 

Expired

 

(60,275)

 

 

 

 

 

17.51

 

 

 

Forfeited

 

(28,669)

 

 

 

 

 

16.70

 

 

 

Balance at December 31, 2017

 

2,069,802

 

 

 

 

 

12.13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable options at December 31, 2016

 

3,048,020

 

 

 

 

 

10.69

 

5.4

 

Vested and expected to vest at December 31, 2016

 

3,733,643

 

 

 

 

 

11.52

 

5.8

 

Exercisable options at December 31, 2017

 

1,786,261

 

 

 

 

 

11.93

 

5.0

 

Vested and expected to vest at December 31, 2017

 

2,069,802

 

 

 

 

 

12.13

 

5.3

 

 

Summary of stock options outstanding and exercisable

The following table summarizes information about stock options outstanding and exercisable at December 31, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

    

 

 

    

 

    

Weighted-

    

 

    

Weighted-

 

 

 

 

 

 

Weighted

 

 

 

Average

 

 

 

Average

 

 

 

 

 

 

Average

 

Number of

 

Remaining

 

Number of

 

Remaining

 

 

 

 

 

 

Exercise

 

Underlying

 

Contractual

 

Underlying

 

Contractual

 

Range of Exercise Prices

    

Price

    

Shares

    

Life (in years)

    

Shares

    

Life (in years)

  

$

4.78

-

7.28

 

 

6.01

 

703,312

 

3.5

 

693,299

 

3.4

 

$

7.49

-

11.29

 

 

10.01

 

434,929

 

5.5

 

338,311

 

5.1

 

$

11.72

-

17.66

 

 

14.70

 

483,862

 

6.9

 

335,285

 

6.9

 

$

19.56

-

22.92

 

 

21.02

 

447,699

 

6.1

 

419,366

 

6.1

 

 

 

 

 

 

 

 

 

2,069,802

 

 

 

1,786,261

 

 

 

 

Summary of aggregate intrinsic-value of options exercised, exercisable, and vested and expected to vest

The following table summarizes the aggregate intrinsic‑value of options exercised, outstanding and exercisable (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Years Ended

 

 

 

and as of December 31,

 

 

 

2017

    

2016

    

2015

 

Options Exercised

 

$

19,966

 

$

3,312

 

$

1,432

 

Options Exercisable

 

 

31,841

 

 

6,089

 

 

3,496

 

Options Vested and Expected to Vest

 

 

36,489

 

 

6,280

 

 

3,499

 

 

Schedule of assumptions used to estimate fair value of option awards

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

2016

    

 

2015

 

Expected volatility

 

 

 

62

%  

 

51

-

55

%  

Expected dividends

 

 

 

0

%  

 

0

%  

Expected terms (in years)

 

 

 

6.1

 

 

5.3

-

6.1

 

Risk-free rate

 

 

 

1.1

%  

 

1.3

-

1.8

%  

 

Summary of restricted stock unit activity

 

 

 

 

 

 

 

 

 

Number of

 

Weighted Average

 

 

    

Shares

    

Grant Date Fair Value

 

Non-vested balance at December 31, 2014

 

 —

 

 

 

 

Awarded

 

433,000

 

$

8.18

 

Forfeited

 

(8,000)

 

 

8.18

 

Non-vested balance at December 31, 2015

 

425,000

 

 

8.18

 

Awarded

 

1,147,946

 

 

7.40

 

Vested

 

(35,340)

 

 

7.85

 

Forfeited

 

(141,219)

 

 

7.66

 

Non-vested balance at December 31, 2016

 

1,396,387

 

 

7.60

 

Awarded

 

783,060

 

 

11.28

 

Vested

 

(823,620)

 

 

7.62

 

Forfeited

 

(65,167)

 

 

8.82

 

Non-vested balance at December 31, 2017

 

1,290,660

 

 

9.75

 

 

Schedule of total stock-based compensation expense classified in Statements of Operations

Total stock‑based compensation expense has been classified as follows in the accompanying Consolidated Statements of Operations (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended

 

 

 

December 31,

 

 

 

2017

    

2016

    

2015

 

Cost of revenue

 

$

251

 

$

171

 

$

174

 

Research and development

 

 

4,242

 

 

3,256

 

 

2,885

 

Sales and marketing

 

 

3,662

 

 

2,273

 

 

1,783

 

General and administrative

 

 

3,950

 

 

2,670

 

 

2,192

 

Total stock-based compensation expense

 

$

12,105

 

$

8,370

 

$

7,034